Edwards Lifesciences ROA 2010-2025 | EW
Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Edwards Lifesciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $4.18B | $0.00B | 46.29% |
| 2024-12-31 | $4.18B | $13.06B | 36.41% |
| 2024-09-30 | $4.16B | $12.97B | 39.45% |
| 2024-06-30 | $1.47B | $10.10B | 15.28% |
| 2024-03-31 | $1.41B | $9.74B | 15.09% |
| 2023-12-31 | $1.40B | $9.36B | 15.42% |
| 2023-09-30 | $1.43B | $9.37B | 16.21% |
| 2023-06-30 | $1.39B | $9.00B | 16.08% |
| 2023-03-31 | $1.49B | $8.65B | 17.51% |
| 2022-12-31 | $1.52B | $8.29B | 18.02% |
| 2022-09-30 | $1.46B | $8.64B | 17.17% |
| 2022-06-30 | $1.46B | $8.43B | 17.37% |
| 2022-03-31 | $1.54B | $8.42B | 18.80% |
| 2021-12-31 | $1.50B | $8.50B | 19.06% |
| 2021-09-30 | $1.48B | $8.16B | 19.53% |
| 2021-06-30 | $1.46B | $7.66B | 20.24% |
| 2021-03-31 | $0.85B | $7.21B | 12.30% |
| 2020-12-31 | $0.82B | $7.24B | 12.42% |
| 2020-09-30 | $0.79B | $6.80B | 12.32% |
| 2020-06-30 | $0.74B | $6.42B | 11.93% |
| 2020-03-31 | $1.11B | $6.08B | 18.39% |
| 2019-12-31 | $1.05B | $6.49B | 17.82% |
| 2019-09-30 | $0.77B | $5.97B | 13.86% |
| 2019-06-30 | $0.73B | $5.57B | 12.99% |
| 2019-03-31 | $0.77B | $5.47B | 13.66% |
| 2018-12-31 | $0.72B | $5.32B | 12.69% |
| 2018-09-30 | $0.71B | $5.96B | 12.33% |
| 2018-06-30 | $0.66B | $5.69B | 11.59% |
| 2018-03-31 | $0.56B | $5.83B | 10.13% |
| 2017-12-31 | $0.58B | $5.67B | 11.07% |
| 2017-09-30 | $0.75B | $5.49B | 14.96% |
| 2017-06-30 | $0.72B | $5.14B | 15.26% |
| 2017-03-31 | $0.66B | $4.78B | 14.86% |
| 2016-12-31 | $0.57B | $4.51B | 13.61% |
| 2016-09-30 | $0.55B | $4.34B | 13.55% |
| 2016-06-30 | $0.53B | $4.05B | 13.36% |
| 2016-03-31 | $0.52B | $3.85B | 13.38% |
| 2015-12-31 | $0.50B | $4.06B | 13.17% |
| 2015-09-30 | $0.46B | $3.88B | 12.78% |
| 2015-06-30 | $0.44B | $3.61B | 12.60% |
| 2015-03-31 | $0.87B | $3.49B | 25.54% |
| 2014-12-31 | $0.81B | $3.52B | 25.24% |
| 2014-09-30 | $0.78B | $3.35B | 25.82% |
| 2014-06-30 | $0.76B | $3.33B | 27.06% |
| 2014-03-31 | $0.31B | $2.65B | 11.92% |
| 2013-12-31 | $0.39B | $2.71B | 15.75% |
| 2013-09-30 | $0.40B | $2.53B | 17.17% |
| 2013-06-30 | $0.40B | $2.34B | 17.45% |
| 2013-03-31 | $0.37B | $2.30B | 16.84% |
| 2012-12-31 | $0.29B | $2.22B | 13.70% |
| 2012-09-30 | $0.27B | $2.20B | 12.84% |
| 2012-06-30 | $0.25B | $2.08B | 12.33% |
| 2012-03-31 | $0.24B | $2.00B | 11.94% |
| 2011-12-31 | $0.24B | $1.98B | 12.00% |
| 2011-09-30 | $0.24B | $1.98B | 12.44% |
| 2011-06-30 | $0.24B | $2.00B | 12.66% |
| 2011-03-31 | $0.24B | $1.93B | 13.31% |
| 2010-12-31 | $0.22B | $1.77B | 13.00% |
| 2010-09-30 | $0.20B | $1.73B | 12.27% |
| 2010-06-30 | $0.23B | $1.64B | 14.11% |
| 2010-03-31 | $0.22B | $1.60B | 13.87% |
| 2009-12-31 | $0.23B | $1.62B | 15.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $44.472B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $189.754B | 83.11 |
| Thermo Fisher Scientific (TMO) | United States | $159.887B | 19.34 |
| Alcon (ALC) | Switzerland | $48.486B | 32.23 |
| IDEXX Laboratories (IDXX) | United States | $37.951B | 43.61 |
| DexCom (DXCM) | United States | $32.004B | 49.47 |
| IQVIA Holdings (IQV) | United States | $27.061B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.925B | 27.19 |
| STERIS (STE) | Ireland | $22.088B | 25.26 |
| Waters (WAT) | United States | $20.850B | 29.52 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.568B | 0.00 |
| Hologic (HOLX) | United States | $12.153B | 13.11 |
| Sysmex ADR (SSMXY) | Japan | $11.545B | 0.00 |
| Penumbra (PEN) | United States | $11.463B | 89.97 |
| Globus Medical (GMED) | United States | $9.891B | 22.90 |
| Masimo (MASI) | United States | $8.993B | 37.74 |
| Teleflex (TFX) | United States | $5.586B | 9.22 |
| Glaukos (GKOS) | United States | $5.006B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.385B | 22.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.077B | 0.00 |
| TransMedics (TMDX) | United States | $3.044B | 89.09 |
| Veracyte (VCYT) | United States | $2.377B | 42.75 |
| Nihon Kohden (NHNKY) | Japan | $2.113B | 11.55 |
| LivaNova (LIVN) | United Kingdom | $2.005B | 12.14 |
| Elekta AB (EKTAY) | Sweden | $1.960B | 17.62 |
| Alphatec Holdings (ATEC) | United States | $1.754B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.302B | 6.58 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.098B | 0.00 |
| Artivion (AORT) | United States | $0.996B | 93.32 |
| AxoGen (AXGN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.680B | 35.65 |
| Mesa Laboratories (MLAB) | United States | $0.647B | 14.14 |
| RxSight (RXST) | United States | $0.644B | 0.00 |
| SiBone (SIBN) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 9.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.538B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.520B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.513B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.457B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.415B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.404B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.377B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.36 |
| Pacific Biosciences Of California (PACB) | United States | $0.339B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.333B | 17.82 |
| Neuronetics (STIM) | United States | $0.301B | 0.00 |
| CVRx (CVRX) | United States | $0.207B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Inogen (INGN) | United States | $0.194B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.183B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.160B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.158B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| InspireMD (NSPR) | Israel | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 10.82 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.036B | 0.00 | |
| Biosig Technologies (BSGM) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |